SIRT1调控Nrf2/HO-1信号通路在脓毒症肝损伤中的作用及机制
研究将24只雄性SD大鼠随机分为假手术组、盲肠结扎穿孔(CLP)组、SIRT1激动剂SRT1720预处理组和SIRT1抑制剂EX527预处理组,每组6只,术前2小时分别腹腔注射SRT1720(10 mg/kg)或EX527(10 mg/kg)。结果显示CLP组血清IL-6、IL-1β、TNF-α、ALT、AST升高,肝组织MDA、8-OHdG升高、GSH、SOD降低,SIRT1、Nrf2、HO-1 mRNA及蛋白表达降低。与CLP组相比,SRT1720预处理组上述炎症因子、氧化应激指标及肝酶降低,SIRT1、Nrf2、HO-1表达升高(均P<0.05);EX527预处理组则呈相反变化(均P<0.05)。结论提示SIRT1通过激活Nrf2/HO-1信号通路抑制促炎因子释放、减轻肝细胞氧化损伤,对CLP诱导的肝损伤发挥保护作用。
要点
- 24只雄性SD大鼠随机分4组(每组6只):假手术组、CLP组、CLP+SRT1720组、CLP+EX527组。
- 术前2小时腹腔注射SRT1720(10 mg/kg)或EX527(10 mg/kg)。
- SRT1720预处理组较CLP组:IL-6 34.59±4.21 vs. 61.84±3.78 ng/L,TNF-α 76.43±5.23 vs. 130.85±5.30 ng/L,ALT 30.71±3.63 vs. 64.23±4.59 U/L,均P<0.05。
- SRT1720预处理组较CLP组:MDA 6.11±0.28 vs. 9.23±0.29 μmol/g,8-OHdG 117.43±10.38 vs. 242.37±11.71 ng/L,GSH 11.93±0.88 vs. 7.66±0.47 μmol/g,SOD 121.58±5.05 vs. 83.57±4.84 kU/g,均P<0.05。
- EX527预处理组较CLP组炎症因子与氧化应激进一步升高(如TNF-α 177.67±5.12 vs. 130.85±5.30 ng/L,ALT 89.33±9.52 vs. 64.23±4.59 U/L,均P<0.05)。
适用人群与场景
- 雄性Sprague-Dawley(SD)大鼠,盲肠结扎穿孔(CLP)诱导脓毒症模型;术前2小时给药,造模后24小时采腹主动脉血并处死取肝组织。
处置流程与药物剂量
- CLP+SRT1720组于术前2小时腹腔注射SIRT1激动剂SRT1720 10 mg/kg。
- CLP+EX527组于术前2小时腹腔注射SIRT1抑制剂EX527 10 mg/kg。
研究设计与关键结果
- 研究类型:动物实验;样本量:24只雄性SD大鼠,随机分为假手术组、CLP组、CLP+SRT1720组、CLP+EX527组,每组6只。
- 与假手术组比较,CLP组血清IL-6、IL-1β、TNF-α、ALT、AST显著升高;肝组织病理示肝索紊乱、肝细胞肿胀坏死、大量炎性细胞浸润;肝组织MDA、8-OHdG含量升高,GSH、SOD含量降低;肝组织SIRT1、Nrf2、HO-1 mRNA及蛋白表达显著降低。
- 与CLP组比较,CLP+SRT1720组炎症因子及氧化应激水平显著降低,SIRT1、Nrf2、HO-1 mRNA及蛋白表达显著升高:IL-6(ng/L)34.59±4.21 vs. 61.84±3.78,IL-1β(ng/L)41.37±2.70 vs. 72.06±3.14,TNF-α(ng/L)76.43±5.23 vs. 130.85±5.30,ALT(U/L)30.71±3.63 vs. 64.23±4.59,AST(U/L)94.57±6.08 vs. 145.15±6.86,MDA(μmol/g)6.11±0.28 vs. 9.23±0.29,8-OHdG(ng/L)117.43±10.38 vs. 242.37±11.71,GSH(μmol/g)11.93±0.88 vs. 7.66±0.47,SOD(kU/g)121.58±5.05 vs. 83.57±4.84,SIRT1
- 与CLP组比较,CLP+EX527组呈相反效应:IL-6(ng/L)81.05±6.47 vs. 61.84±3.78,IL-1β(ng/L)93.89±5.83 vs. 72.06±3.14,TNF-α(ng/L)177.67±5.12 vs. 130.85±5.30,ALT(U/L)89.33±9.52 vs. 64.23±4.59,AST(U/L)179.59±6.44 vs. 145.15±6.86,MDA(μmol/g)11.39±0.51 vs. 9.23±0.29,8-OHdG(ng/L)328.83±11.26 vs. 242.37±11.71,GSH(μmol/g)5.07±0.34 vs. 7.66±0.47,SOD(kU/g)59.37±4.28 vs. 83.57±4.84,SIRT1 mRNA(2-ΔΔCt)0.34±0.03 vs. 0.46±0.02,Nrf2
证据类型、等级与局限
- 证据类型:动物实验(大鼠CLP脓毒症模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为:SIRT1可通过激活Nrf2/HO-1信号通路抑制促炎因子释放、减轻肝细胞氧化损伤,从而对CLP诱导的肝损伤发挥保护作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the role and mechanism of silent information regulator 1 (SIRT1) in regulating nuclear factor E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway in oxidative stress and inflammatory response to sepsis-induced liver injury.
METHODS: A total of 24 male Sprague-Dawley (SD) rats were randomly divided into sham operation (Sham) group, cecal ligation and puncture (CLP) group, SIRT1 agonist SRT1720 pretreatment (CLP+SRT1720) group and SIRT1 inhibitor EX527 pretreatment (CLP+EX527) group, with 6 rats in each group. Two hours before operation, SRT1720 (10 mg/kg) or EX527 (10 mg/kg) were intraperitoneally injected into the CLP+SRT1720 group and CLP+EX527 group, respectively. Blood was collected from the abdominal aorta at 24 hours after modeling and the rats were sacrificed for liver tissue. The serum levels of interleukins (IL-6, IL-1β) and tumor necrosis factor-α (TNF-α) were detected by enzyme-linked immunosorbent assay (ELISA). The serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were detected by microplate method. Hematoxylin-eosin (HE) staining was used to observe the pathological injury of rats in each group. The levels of malondialdehyde (MDA), 8-hydroxydeoxyguanosine (8-OHdG), glutathione (GSH) and superoxide dismutase (SOD) in liver tissue were detected by corresponding kits. The mRNA and protein expressions of SIRT1, Nrf2 and HO-1 in liver tissues were detected by real-time quantitative polymerase chain reaction (RT-qPCR) and Western blotting.
RESULTS: Compared with the Sham group, the serum levels of IL-6, IL-1β, TNF-α, ALT and AST in the CLP group were significantly increased; histopathological results showed that liver cords were disordered, hepatocytes were swollen and necrotic, and a large number of inflammatory cells infiltrated; the contents of MDA and 8-OHdG in liver tissue increased, while the contents of GSH and SOD decreased; and the mRNA and protein expressions of SIRT1, Nrf2 and HO-1 in liver tissues were significantly decreased. These results suggest that sepsis rats have liver dysfunction, and the levels of SIRT1, Nrf2, HO-1 and antioxidant protein in liver tissues were decreased, while the levels of oxidative stress and inflammation were increased. Compared with the CLP group, the levels of inflammatory factors and oxidative stress were significantly decreased in the CLP+SRT1720 group, the mRNA and protein expressions of SIRT1, Nrf2 and HO-1 were significantly increased [IL-6 (ng/L): 34.59±4.21 vs. 61.84±3.78, IL-1β (ng/L): 41.37±2.70 vs. 72.06±3.14, TNF-α (ng/L): 76.43±5.23 vs. 130.85±5.30, ALT (U/L): 30.71±3.63 vs. 64.23±4.59, AST (U/L): 94.57±6.08 vs. 145.15±6.86, MDA (μmol/g): 6.11±0.28 vs. 9.23±0.29, 8-OHdG (ng/L): 117.43±10.38 vs. 242.37±11.71, GSH (μmol/g): 11.93±0.88 vs. 7.66±0.47, SOD (kU/g): 121.58±5.05 vs. 83.57±4.84, SIRT1 mRNA (2-ΔΔCt): 1.20±0.13 vs. 0.46±0.02, Nrf2 mRNA (2-ΔΔCt): 1.21±0.12 vs. 0.58±0.03, HO-1 mRNA (2-ΔΔCt): 1.71±0.06 vs. 0.48±0.07, SIRT1 protein (SIRT1/β-actin): 0.89±0.04 vs. 0.58±0.03, Nrf2 protein (Nrf2/β-actin): 0.87±0.08 vs. 0.51±0.09, HO-1 protein (HO-1/β-actin): 0.93±0.14 vs. 0.54±0.12, all P < 0.05], these results indicated that SIRT1 agonist SRT1720 pretreatment could improve liver injury in sepsis rats. However, pretreatment with SIRT1 inhibitor EX527 showed the opposite effect [IL-6 (ng/L): 81.05±6.47 vs. 61.84±3.78, IL-1β (ng/L): 93.89±5.83 vs. 72.06±3.14, TNF-α (ng/L): 177.67±5.12 vs. 130.85±5.30, ALT (U/L): 89.33±9.52 vs. 64.23±4.59, AST (U/L): 179.59±6.44 vs. 145.15±6.86, MDA (μmol/g): 11.39±0.51 vs. 9.23±0.29, 8-OHdG (ng/L): 328.83±11.26 vs. 242.37±11.71, GSH (μmol/g): 5.07±0.34 vs. 7.66±0.47, SOD (kU/g): 59.37±4.28 vs. 83.57±4.84, SIRT1 mRNA (2-ΔΔCt): 0.34±0.03 vs. 0.46±0.02, Nrf2 mRNA (2-ΔΔCt): 0.46±0.04 vs. 0.58±0.03, HO-1 mRNA (2-ΔΔCt): 0.21±0.03 vs. 0.48±0.07, SIRT1 protein (SIRT1/β-actin): 0.47±0.04 vs. 0.58±0.03, Nrf2 protein (Nrf2/β-actin): 0.32±0.07 vs. 0.51±0.09, HO-1 protein (HO-1/β-actin): 0.19±0.09 vs. 0.54±0.12, all P < 0.05].
CONCLUSIONS: SIRT1 can inhibit the release of proinflammatory factors and alleviate the oxidative damage of hepatocytes by activating Nrf2/HO-1 signaling pathway, thus playing a protective role against CLP-induced liver injury.
参考来源
- Chen M, Zhang Y, Wang Y, et al. [Role and mechanism of SIRT1 in regulating Nrf2/HO-1 signaling pathway in septic liver injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37366125. doi:10.3760/cma.j.cn121430-20220815-00744
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。